Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jan;78(1):e28-e31.
doi: 10.1016/j.jhep.2022.09.015. Epub 2022 Sep 27.

Cirrhosis is an independent predictor for COVID-19 mortality: A meta-analysis of confounding cofactors-controlled data

Ying Wang  1 , Mengke Hu  1 , Haiyan Yang  2
Affiliations
Meta-Analysis

Cirrhosis is an independent predictor for COVID-19 mortality: A meta-analysis of confounding cofactors-controlled data

Ying Wang et al. J Hepatol. 2023 Jan.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Forest plots of pooled effect size and sensitivity analysis of the association between cirrhosis and COVID-19 mortality. (A) Forest plot presenting the pooled effect size on the association between cirrhosis and COVID-19 mortality, on the basis of confounding cofactors-controlled data, ∗indicates combined effects based on subgroups; (B) A sensitivity analysis (based on omitting a single study each time) showed that our results were stable and robust.
See this image and copyright information in PMC

Comment in

Comment on

  • Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
    Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, Pose E, Brenner EJ, Cargill T, Catana MA, Dhanasekaran R, Eshraghian A, García-Juárez I, Gill US, Jones PD, Kennedy J, Marshall A, Matthews C, Mells G, Mercer C, Perumalswami PV, Avitabile E, Qi X, Su F, Ufere NN, Wong YJ, Zheng MH, Barnes E, Barritt AS 4th, Webb GJ. Marjot T, et al. J Hepatol. 2021 Mar;74(3):567-577. doi: 10.1016/j.jhep.2020.09.024. Epub 2020 Oct 6. J Hepatol. 2021. PMID: 33035628 Free PMC article.

References

    1. Marjot T., Moon A.M., Cook J.A., Abd-Elsalam S., Aloman C., Armstrong M.J., et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2021;74:567–577. - PMC - PubMed
    1. Bushman D., Davidson A., Pathela P., Greene S.K., Weiss D., Reddy V., et al. Risk factors for death among hospitalized patients aged 21-64 Years diagnosed with COVID-19-New York city, March 13–April 9, 2020. J racial ethnic Health disparities. 2022;9:1584–1599. - PMC - PubMed
    1. Calderon-Parra J., Cuervas-Mons V., Moreno-Torres V., Rubio-Rivas M., Blas P.A., Pinilla-Llorente B., et al. Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry. Int J Infect Dis : IJID : official Publ Int Soc Infect Dis. 2022;116:51–58. - PMC - PubMed
    1. Castilla J., Guevara M., Miqueleiz A., Baigorria F., Ibero-Esparza C., Navascues A., et al. Risk factors of infection, hospitalization and death from SARS-CoV-2: a population-based cohort study. J Clin Med. 2021:10. - PMC - PubMed
    1. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6 - PMC - PubMed